iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
2.005
-0.185 (-8.45%)
Mar 19, 2026, 12:26 PM EDT - Market open
iBio, Inc. Employees
iBio, Inc. had 20 employees as of June 30, 2025. The number of employees increased by 4 or 25.00% compared to the previous year.
Employees
20
Change (1Y)
4
Growth (1Y)
25.00%
Revenue / Employee
$15,000
Profits / Employee
-$1,236,850
Market Cap
69.26M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 20 | 4 | 25.00% | 20 | 0 |
| Jun 30, 2024 | 16 | -10 | -38.46% | 16 | 0 |
| Jun 30, 2023 | 26 | -80 | -75.47% | 26 | 0 |
| Jun 30, 2022 | 106 | 31 | 41.33% | 105 | 1 |
| Jun 30, 2021 | 75 | 24 | 47.06% | 49 | 26 |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Pliant Therapeutics | 171 |
| Seres Therapeutics | 103 |
| PolyPid | 73 |
| aTyr Pharma | 60 |
| PMV Pharmaceuticals | 54 |
| Biomea Fusion | 42 |
| Vivani Medical | 37 |
IBIO News
- 1 day ago - iBio, Inc. (IBIO) Discusses Bispecific Antibody Program and Rationale for Targeting Pulmonary Hypertension in Heart Failure Transcript - Seeking Alpha
- 2 days ago - iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - GlobeNewsWire
- 10 days ago - iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss - GlobeNewsWire
- 23 days ago - iBio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - iBio Announces $26 Million Private Placement - GlobeNewsWire
- 4 months ago - iBio to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 4 months ago - iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewsWire